Selected research
Industry Research
Medicinal Carbon Industry Research Report 2026
Market perspective
The global Medicinal Carbon market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medicinal Carbon is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medicinal Carbon is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medicinal Carbon is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medicinal Carbon include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medicinal Carbon market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Medicinal Carbon.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medicinal Carbon Market by Company
NORIT
Dupont
Witco Chemical Corporation
Osaka Gas Co.,Ltd.
Kuraray
Ingevity
Haycarb PLC
Emis Vito
EcoFriend Carbon
Dolder
Calgon Carbon Corporation
Barnebey Cheney
Atlas Carbon
Medicinal Carbon Segment by Type
Chemical Activation
Physical Activation
Medicinal Carbon Segment by Application
Ostomy
Decolourisation of Pharmaceuticals
Dialysis/Blood Cleaning
Wound Odour Removal
Emergency Poison Antidote
Medicinal Carbon Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicinal Carbon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicinal Carbon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicinal Carbon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medicinal Carbon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medicinal Carbon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medicinal Carbon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Activation
- Physical Activation
Applications
- Ostomy
- Decolourisation of Pharmaceuticals
- Dialysis/Blood Cleaning
- Wound Odour Removal
- Emergency Poison Antidote
Companies covered
- NORIT
- Dupont
- Witco Chemical Corporation
- Osaka Gas Co.,Ltd.
- Kuraray
- Ingevity
- Haycarb PLC
- Emis Vito
- EcoFriend Carbon
- Dolder
- Calgon Carbon Corporation
- Barnebey Cheney
- Atlas Carbon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medicinal Carbon by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Chemical Activation
- 2.2.3 Physical Activation
- 2.3 Medicinal Carbon by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ostomy
- 2.3.3 Decolourisation of Pharmaceuticals
- 2.3.4 Dialysis/Blood Cleaning
- 2.3.5 Wound Odour Removal
- 2.3.6 Emergency Poison Antidote
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Medicinal Carbon Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Medicinal Carbon Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Medicinal Carbon Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Medicinal Carbon Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medicinal Carbon Production by Manufacturers (2021-2026)
- 3.2 Global Medicinal Carbon Production Value by Manufacturers (2021-2026)
- 3.3 Global Medicinal Carbon Average Price by Manufacturers (2021-2026)
- 3.4 Global Medicinal Carbon Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medicinal Carbon Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Medicinal Carbon Manufacturers, Product Type & Application
- 3.7 Global Medicinal Carbon Manufacturers Established Date
- 3.8 Global Medicinal Carbon Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 NORIT
- 4.1.1 NORIT Medicinal Carbon Company Information
- 4.1.2 NORIT Medicinal Carbon Business Overview
- 4.1.3 NORIT Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 NORIT Product Portfolio
- 4.1.5 NORIT Recent Developments
- 4.2 Dupont
- 4.2.1 Dupont Medicinal Carbon Company Information
- 4.2.2 Dupont Medicinal Carbon Business Overview
- 4.2.3 Dupont Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Dupont Product Portfolio
- 4.2.5 Dupont Recent Developments
- 4.3 Witco Chemical Corporation
- 4.3.1 Witco Chemical Corporation Medicinal Carbon Company Information
- 4.3.2 Witco Chemical Corporation Medicinal Carbon Business Overview
- 4.3.3 Witco Chemical Corporation Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Witco Chemical Corporation Product Portfolio
- 4.3.5 Witco Chemical Corporation Recent Developments
- 4.4 Osaka Gas Co.,Ltd.
- 4.4.1 Osaka Gas Co.,Ltd. Medicinal Carbon Company Information
- 4.4.2 Osaka Gas Co.,Ltd. Medicinal Carbon Business Overview
- 4.4.3 Osaka Gas Co.,Ltd. Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Osaka Gas Co.,Ltd. Product Portfolio
- 4.4.5 Osaka Gas Co.,Ltd. Recent Developments
- 4.5 Kuraray
- 4.5.1 Kuraray Medicinal Carbon Company Information
- 4.5.2 Kuraray Medicinal Carbon Business Overview
- 4.5.3 Kuraray Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Kuraray Product Portfolio
- 4.5.5 Kuraray Recent Developments
- 4.6 Ingevity
- 4.6.1 Ingevity Medicinal Carbon Company Information
- 4.6.2 Ingevity Medicinal Carbon Business Overview
- 4.6.3 Ingevity Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Ingevity Product Portfolio
- 4.6.5 Ingevity Recent Developments
- 4.7 Haycarb PLC
- 4.7.1 Haycarb PLC Medicinal Carbon Company Information
- 4.7.2 Haycarb PLC Medicinal Carbon Business Overview
- 4.7.3 Haycarb PLC Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Haycarb PLC Product Portfolio
- 4.7.5 Haycarb PLC Recent Developments
- 4.8 Emis Vito
- 4.8.1 Emis Vito Medicinal Carbon Company Information
- 4.8.2 Emis Vito Medicinal Carbon Business Overview
- 4.8.3 Emis Vito Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Emis Vito Product Portfolio
- 4.8.5 Emis Vito Recent Developments
- 4.9 EcoFriend Carbon
- 4.9.1 EcoFriend Carbon Medicinal Carbon Company Information
- 4.9.2 EcoFriend Carbon Medicinal Carbon Business Overview
- 4.9.3 EcoFriend Carbon Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 EcoFriend Carbon Product Portfolio
- 4.9.5 EcoFriend Carbon Recent Developments
- 4.10 Dolder
- 4.10.1 Dolder Medicinal Carbon Company Information
- 4.10.2 Dolder Medicinal Carbon Business Overview
- 4.10.3 Dolder Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Dolder Product Portfolio
- 4.10.5 Dolder Recent Developments
- 4.11 Calgon Carbon Corporation
- 4.11.1 Calgon Carbon Corporation Medicinal Carbon Company Information
- 4.11.2 Calgon Carbon Corporation Medicinal Carbon Business Overview
- 4.11.3 Calgon Carbon Corporation Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Calgon Carbon Corporation Product Portfolio
- 4.11.5 Calgon Carbon Corporation Recent Developments
- 4.12 Barnebey Cheney
- 4.12.1 Barnebey Cheney Medicinal Carbon Company Information
- 4.12.2 Barnebey Cheney Medicinal Carbon Business Overview
- 4.12.3 Barnebey Cheney Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Barnebey Cheney Product Portfolio
- 4.12.5 Barnebey Cheney Recent Developments
- 4.13 Atlas Carbon
- 4.13.1 Atlas Carbon Medicinal Carbon Company Information
- 4.13.2 Atlas Carbon Medicinal Carbon Business Overview
- 4.13.3 Atlas Carbon Medicinal Carbon Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Atlas Carbon Product Portfolio
- 4.13.5 Atlas Carbon Recent Developments
5 Global Medicinal Carbon Production by Region
- 5.1 Global Medicinal Carbon Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medicinal Carbon Production by Region: 2021-2032
- 5.2.1 Global Medicinal Carbon Production by Region: 2021-2026
- 5.2.2 Global Medicinal Carbon Production Forecast by Region (2027-2032)
- 5.3 Global Medicinal Carbon Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Medicinal Carbon Production Value by Region: 2021-2032
- 5.4.1 Global Medicinal Carbon Production Value by Region: 2021-2026
- 5.4.2 Global Medicinal Carbon Production Value Forecast by Region (2027-2032)
- 5.5 Global Medicinal Carbon Market Price Analysis by Region (2021-2026)
- 5.6 Global Medicinal Carbon Production and Value, YOY Growth
- 5.6.1 North America Medicinal Carbon Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Medicinal Carbon Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Medicinal Carbon Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Medicinal Carbon Production Value Estimates and Forecasts (2021-2032)
6 Global Medicinal Carbon Consumption by Region
- 6.1 Global Medicinal Carbon Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medicinal Carbon Consumption by Region (2021-2032)
- 6.2.1 Global Medicinal Carbon Consumption by Region: 2021-2026
- 6.2.2 Global Medicinal Carbon Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medicinal Carbon Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medicinal Carbon Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medicinal Carbon Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medicinal Carbon Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medicinal Carbon Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medicinal Carbon Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Medicinal Carbon Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Medicinal Carbon Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Medicinal Carbon Production by Type (2021-2032)
- 7.1.1 Global Medicinal Carbon Production by Type (2021-2032) & (t)
- 7.1.2 Global Medicinal Carbon Production Market Share by Type (2021-2032)
- 7.2 Global Medicinal Carbon Production Value by Type (2021-2032)
- 7.2.1 Global Medicinal Carbon Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Medicinal Carbon Production Value Market Share by Type (2021-2032)
- 7.3 Global Medicinal Carbon Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Medicinal Carbon Production by Application (2021-2032)
- 8.1.1 Global Medicinal Carbon Production by Application (2021-2032) & (t)
- 8.1.2 Global Medicinal Carbon Production Market Share by Application (2021-2032)
- 8.2 Global Medicinal Carbon Production Value by Application (2021-2032)
- 8.2.1 Global Medicinal Carbon Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Medicinal Carbon Production Value Market Share by Application (2021-2032)
- 8.3 Global Medicinal Carbon Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Medicinal Carbon Value Chain Analysis
- 9.1.1 Medicinal Carbon Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Medicinal Carbon Production Mode & Process
- 9.2 Medicinal Carbon Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medicinal Carbon Distributors
- 9.2.3 Medicinal Carbon Customers
10 Global Medicinal Carbon Analyzing Market Dynamics
- 10.1 Medicinal Carbon Industry Trends
- 10.2 Medicinal Carbon Industry Drivers
- 10.3 Medicinal Carbon Industry Opportunities and Challenges
- 10.4 Medicinal Carbon Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst